Cargando…

Development of an antibiotic marker-free platform for heterologous protein production in Streptomyces

BACKGROUND: The industrial use of enzymes produced by microorganisms is continuously growing due to the need for sustainable solutions. Nevertheless, many of the plasmids used for recombinant production of proteins in bacteria are based on the use of antibiotic resistance genes as selection markers....

Descripción completa

Detalles Bibliográficos
Autores principales: Sevillano, Laura, Díaz, Margarita, Santamaría, Ramón I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615484/
https://www.ncbi.nlm.nih.gov/pubmed/28950904
http://dx.doi.org/10.1186/s12934-017-0781-y
_version_ 1783266595411329024
author Sevillano, Laura
Díaz, Margarita
Santamaría, Ramón I.
author_facet Sevillano, Laura
Díaz, Margarita
Santamaría, Ramón I.
author_sort Sevillano, Laura
collection PubMed
description BACKGROUND: The industrial use of enzymes produced by microorganisms is continuously growing due to the need for sustainable solutions. Nevertheless, many of the plasmids used for recombinant production of proteins in bacteria are based on the use of antibiotic resistance genes as selection markers. The safety concerns and legal requirements surrounding the increased use of antibiotic resistance genes have made the development of new antibiotic-free approaches essential. RESULTS: In this work, a system completely free of antibiotic resistance genes and useful for the production of high yields of proteins in Streptomyces is described. This system is based on the separation of the two components of the yefM/yoeBsl (antitoxin/toxin) operon; the toxin (yoeBsl) gene, responsible for host death, is integrated into the genome and the antitoxin gene (yefMsl), which inactivates the toxin, is located in the expression plasmid. To develop this system, the toxin gene was integrated into the genome of a strain lacking the complete operon, and the antibiotic resistance gene integrated along with the toxin was eliminated by Cre recombinase to generate a final host strain free of any antibiotic resistance marker. In the same way, the antibiotic resistance gene from the final expression plasmid was removed by Dre recombinase. The usefulness of this system was analysed by checking the production of two hydrolases from different Streptomyces. Production of both proteins, with potential industrial use, was high and stable over time after strain storage and after serial subcultures. These results support the robustness and stability of the positive selection system developed. CONCLUSIONS: The total absence of antibiotic resistance genes makes this system a powerful tool for using Streptomyces as a host to produce proteins at the industrial level. This work is the first Streptomyces antibiotic marker-free system to be described. [Figure: see text]
format Online
Article
Text
id pubmed-5615484
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56154842017-09-28 Development of an antibiotic marker-free platform for heterologous protein production in Streptomyces Sevillano, Laura Díaz, Margarita Santamaría, Ramón I. Microb Cell Fact Research BACKGROUND: The industrial use of enzymes produced by microorganisms is continuously growing due to the need for sustainable solutions. Nevertheless, many of the plasmids used for recombinant production of proteins in bacteria are based on the use of antibiotic resistance genes as selection markers. The safety concerns and legal requirements surrounding the increased use of antibiotic resistance genes have made the development of new antibiotic-free approaches essential. RESULTS: In this work, a system completely free of antibiotic resistance genes and useful for the production of high yields of proteins in Streptomyces is described. This system is based on the separation of the two components of the yefM/yoeBsl (antitoxin/toxin) operon; the toxin (yoeBsl) gene, responsible for host death, is integrated into the genome and the antitoxin gene (yefMsl), which inactivates the toxin, is located in the expression plasmid. To develop this system, the toxin gene was integrated into the genome of a strain lacking the complete operon, and the antibiotic resistance gene integrated along with the toxin was eliminated by Cre recombinase to generate a final host strain free of any antibiotic resistance marker. In the same way, the antibiotic resistance gene from the final expression plasmid was removed by Dre recombinase. The usefulness of this system was analysed by checking the production of two hydrolases from different Streptomyces. Production of both proteins, with potential industrial use, was high and stable over time after strain storage and after serial subcultures. These results support the robustness and stability of the positive selection system developed. CONCLUSIONS: The total absence of antibiotic resistance genes makes this system a powerful tool for using Streptomyces as a host to produce proteins at the industrial level. This work is the first Streptomyces antibiotic marker-free system to be described. [Figure: see text] BioMed Central 2017-09-26 /pmc/articles/PMC5615484/ /pubmed/28950904 http://dx.doi.org/10.1186/s12934-017-0781-y Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Sevillano, Laura
Díaz, Margarita
Santamaría, Ramón I.
Development of an antibiotic marker-free platform for heterologous protein production in Streptomyces
title Development of an antibiotic marker-free platform for heterologous protein production in Streptomyces
title_full Development of an antibiotic marker-free platform for heterologous protein production in Streptomyces
title_fullStr Development of an antibiotic marker-free platform for heterologous protein production in Streptomyces
title_full_unstemmed Development of an antibiotic marker-free platform for heterologous protein production in Streptomyces
title_short Development of an antibiotic marker-free platform for heterologous protein production in Streptomyces
title_sort development of an antibiotic marker-free platform for heterologous protein production in streptomyces
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615484/
https://www.ncbi.nlm.nih.gov/pubmed/28950904
http://dx.doi.org/10.1186/s12934-017-0781-y
work_keys_str_mv AT sevillanolaura developmentofanantibioticmarkerfreeplatformforheterologousproteinproductioninstreptomyces
AT diazmargarita developmentofanantibioticmarkerfreeplatformforheterologousproteinproductioninstreptomyces
AT santamariaramoni developmentofanantibioticmarkerfreeplatformforheterologousproteinproductioninstreptomyces